Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma

Abstract

Poly Adenylate Binding Protein Interacting protein 1 (PAIP1) plays a critical role in translation initiation and is associated with the several cancer types. However, its function and clinical significance have not yet been described in oral squamous cell carcinoma (OSCC) and its associated features like lymph node metastasis (LNM). Here, we used the data available from Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and Clinical Proteomic Tumor Analysis Consortium (CPTAC) to analyze PAIP1 expression in oral cancer. The publicly available data suggests that PAIP1 mRNA and protein levels were increased in OSCC. The high PAIP1 expression was more evident in samples with advanced stage, LNM, and worse pattern of invasion. Moreover, the in vitro experiments revealed that PAIP1 knockdown attenuated colony forming, the aggressiveness of OSCC cell lines, decreasing MMP9 activity and SRC phosphorylation. Importantly, we found a correlation between PAIP1 and pSRC through the analysis of the IHC scores and CPTAC data in patient samples. Our findings suggest that PAIP1 could be an independent prognostic factor in OSCC with LNM and a suitable therapeutic target to improve OSCC patient outcomes.

References

[1] Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct. Target Ther., 2020, 5: 28.

[2] Montero PH, Patel SG. Cancer of the oral cavity. Surg. Oncol. Clin. N. Am., 2015, 24: 491-508.

[3] Lo Nigro C, Denaro N, Merlotti A, Merlano M. Head and neck cancer: Improving outcomes with a multidisciplinary approach. Cancer Manag. Res., 2017, 9: 363-371.

[4] Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J. Otorhinolaryngol. Relat. Spec., 2001, 63: 202-207.

[5] Roy G, . Paip1 interacts with poly(A) binding protein through two independent binding motifs. Mol. Cell Biol., 2002, 22: 3769-3782.

[6] Scotto L, . Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol. Cancer, 2008, 7

[7] Tang WK, . Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma. Int. J. Mol. Med., 2007, 19: 915-923.

[8] Martineau Y, . Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol. Cell Biol., 2008, 28: 6658-6667.

[9] Craig AW, Haghighat A, Yu AT, Sonenberg N. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature, 1998, 392: 520-523.

[10] Martineau Y, . Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase. Mol. Cell Biol., 2014, 34: 1046-1053.

[11] Piao J, . Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker. Hum. Pathol., 2018, 73: 33-40.

[12] Li N, . Paip1 indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis. Cancer Res. Treat., 2019, 51: 1653-1665.

[13] Wang Q, . Paip1 overexpression is involved in the progression of gastric cancer and predicts shorter survival of diagnosed patients. Onco Targets Ther., 2019, 12: 6565-6576.

[14] Wang Y, . Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3beta pathway in lung adenocarcinoma. Hum. Pathol., 2019, 86: 233-242.

[15] Guan H, . Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp. Cell Res., 2019, 376: 198-209.

[16] Xu, B. et al. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: A comparative study. Virchows Arch. https://doi.org/10.1007/s00428-021-03063-z (2021).

[17] Vincent-Chong VK, . Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance. PLoS One, 2017, 12: e0174865.

[18] Speicher MR, . Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res., 1995, 55: 1010-1013.

[19] Kim H, Jung W, Kim A, Kim HK, Kim BH. High Paip1 expression as a potential prognostic marker in hepatocellular carcinoma. In Vivo, 2020, 34: 2491-2497.

[20] Xie H, . Effects of inducing apoptosis and inhibiting proliferation of siRNA on polyadenylate-binding protein-interacting protein 1 in tongue cell carcinoma. Head Neck, 2020, 42: 3623-3637.

[21] Carnielli CM, . Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat. Commun., 2018, 9

[22] Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J. Pathol., 1992, 166: 375-381.

[23] Bryne M, . New malignancy grading is a better prognostic indicator than Broders’ grading in oral squamous cell carcinomas. J. Oral. Pathol. Med., 1989, 18: 432-437.

[24] Prall F, Ostwald C, Linnebacher M. Tubular invasion and the morphogenesis of tumor budding in colorectal carcinoma. Hum. Pathol., 2009, 40: 1510-1512.

[25] Wang LM, . Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am. J. Surg. Pathol., 2009, 33: 134-141.

[26] Brandwein-Gensler M, . Oral squamous cell carcinoma: Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am. J. Surg. Pathol., 2005, 29: 167-178.

[27] Beggan C, . Pattern of invasion and lymphovascular invasion in squamous cell carcinoma of the floor of the mouth: an interobserver variability study. Histopathology, 2016, 69: 914-920.

[28] Jin X, . Analysis of clinicopathological characteristics associated with the outcome of oral squamous cell carcinoma and the establishment of tissue microarrays. Oncol. Lett., 2016, 12: 3175-3182.

[29] Miguel AFP, Mello FW, Melo G, Rivero ERC. Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis. Head Neck, 2020, 42: 569-584.

[30] Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck, 2007, 29: 564-572.

[31] Nanda DP, . MMP-9 as a potential biomarker for carcinoma of oral cavity: A study in eastern India. Neoplasma, 2014, 61: 747-757.

[32] Deng W, Peng W, Wang T, Chen J, Zhu S. Overexpression of MMPs functions as a prognostic biomarker for oral cancer patients: A systematic review and meta-analysis. Oral. Health Prev. Dent., 2019, 17: 505-514.

[33] Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochim. Biophys. Acta, 2010, 1803: 3-19.

[34] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol., 2014, 15: 178-196.

[35] Meireles Da Costa N, . Potential therapeutic significance of laminin in head and neck squamous carcinomas. Cancers, 2021, 13: 1890.

[36] Harsha C, . Targeting AKT/mTOR in oral cancer: Mechanisms and advances in clinical trials. Int. J. Mol. Sci., 2020, 21: 3285.

[37] Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene, 2000, 19: 5636-5642.

[38] Bjorge JD, Jakymiw A, Fujita DJ. Selected glimpses into the activation and function of Src kinase. Oncogene, 2000, 19: 5620-5635.

[39] Egloff AM, Grandis JR. Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer. Semin. Oncol., 2008, 35: 286-297.

[40] Johnson FM, Gallick GE. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med. Chem., 2007, 7: 651-659.

[41] Chen C, . Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev., 2008, 17: 2152-2162.

[42] Sheu JJ, . LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling. Oncogene, 2014, 33: 1375-1384.

[43] Barrett T, . NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res., 2013, 41: D991-D995.

[44] Huang C, . Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell, 2021, 39: 361-379 e316.

[45] El-Naggar, A. K. et al. (eds.) WHO Classification of Head and Neck Tumours (IARC Press, 2017).

[46] Amin, M. B. et al. (eds.) AJCC Cancer Staging Manual (Springer, 2017).

[47] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001, 25: 402-408.